APTEVO THERAPEUTICS INC - COM NEW (APVO)

CUSIP: 03835L207

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / COM NEW
Total 13F shares
659,105
Share change
+26,946
Total reported value
$5,002,000
Price per share
$7.58
Number of holders
16
Value change
+$50,866
Number of buys
6
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 03835L207?
CUSIP 03835L207 identifies APVO - APTEVO THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of APTEVO THERAPEUTICS INC - COM NEW (APVO) as of Q3 2020

As of 30 Sep 2020, APTEVO THERAPEUTICS INC - COM NEW (APVO) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 659,105 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BANK OF MONTREAL /CAN/, CREDIT SUISSE AG/, ACADIAN ASSET MANAGEMENT LLC, GSA CAPITAL PARTNERS LLP, Worth Venture Partners, LLC, BlackRock Inc., WINTON GROUP Ltd, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 16 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.